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Key Points 
QUESTIONS: Can artificial intelligence technology used to early screen COVID-19 
patients from their computed tomography (CT) images and what is the diagnostic 
accuracy from computer? 
FINDINGS: In this multi-center case study, the overall accuracy of the deep learning 
models were 86.7% for three groups: COVID-19, Influenza-A viral pneumonia and 
healthy cases. 
MEANING: It is fully automatic and could be a promising supplementary diagnostic 
method for frontline clinical doctors. 
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Abstract 
IMPORTANCE: We found that the real time reverse transcription-polymerase chain 
reaction (RT-PCR) detection of viral RNA from sputum or nasopharyngeal swab has 
a relatively low positive rate in the early stage to determine COVID-19 (named by the 
World Health Organization). The manifestations of computed tomography (CT) 
imaging of COVID-19 had their own characteristics, which are different from other 
types of viral pneumonia, such as Influenza-A viral pneumonia. Therefore, clinical 
doctors call for another early diagnostic criteria for this new type of pneumonia as 
soon as possible.  
OBJECTIVE: This study aimed to establish an early screening model to distinguish 
COVID-19 pneumonia from Influenza-A viral pneumonia and healthy cases with 
pulmonary CT images using deep learning techniques. 
DESIGN: The candidate infection regions were first segmented out using a 
3-dimensional deep learning model from pulmonary CT image set. These separated 
images were then categorized into COVID-19, Influenza-A viral pneumonia and 
irrelevant to infection groups, together with the corresponding confidence scores 
using a location-attention classification model. Finally the infection type and total 
confidence score of this CT case were calculated with Noisy-or Bayesian function. 
SETTING: CT samples contributed from three COVID-19 designated hospitals from 
Zhejiang Province, China.  
PARTICIPANTS: A total of 618 CT samples were collected: 219 from 110 patients 
with COVID-19, 224 CT samples from 224 patients with Influenza-A viral 
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pneumonia, and 175 CT samples from healthy people. 
RESULTS: The experiments result of benchmark dataset showed that the overall 
accuracy was 86.7 % from the perspective of CT cases as a whole.  
CONCLUSIONS: The deep learning models established in this study were effective 
for the early screening of COVID-19 patients and demonstrated to be a promising 
supplementary diagnostic method for frontline clinical doctors. 
 
Key words: coronavirus disease 2019 pneumonia, COVID-19, deep learning, 
computed tomography, convolution neural network, location-attention network 
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1. Introduction 
At the end of 2019, the novel coronavirus disease 2019 pneumonia (COVID-19) 
occurred in the city of Wuhan, China.
1-4
 On January 24, 2020, Huang et al.
5
 
summarized the clinical characteristics of 41 patients with COVID-19, indicating that 
the common onset symptoms were fever, cough, myalgia, or fatigue. All these 41 
patients had pneumonia and their chest CT examination showed abnormalities. The 
complications included acute respiratory distress syndrome, acute heart injury, and 
secondary infections. Thirteen (32%) patients were admitted to the intensive care unit 
(ICU), and six (15%) died. The the Kok-KH
6
 team at the University of Hong Kong 
found the evidence of human-to-human transmission of  COVID-19 for the first 
time. 
COVID-19 causes severe respiratory symptoms and is associated with relatively 
high ICU admission and mortality. The current clinical experience for treating these 
patients revealed that the RT-PCR detection of viral RNA from sputum or 
nasopharyngeal swab had a low positive rate in the early stage. However, a high 
proportion of abnormal chest CT images were obtained from patients with this disease. 
The manifestations of CT imaging of COVID-19 cases had their own characteristics, 
different from the manifestations of CT imaging of other viral pneumonia such as 
Influenza-A viral pneumonia, as showed in Figure 1. Therefore, clinical doctors called 
for replacing nucleic acid testing with lung CT as one of the early diagnostic criteria 
for this new type of pneumonia as soon as possible.  
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With the rapid development of computer technology, digital image processing 
technology has been widely applied in the medical field, including organ 
segmentation and image enhancement and repair, providing support for subsequent 
medical diagnosis.
7,8 
Deep learning technologies, such as convolutional neural 
network (CNN) with the strong ability of nonlinear modeling, have extensive 
applications in medical image processing as well.
9-12
 Relevant studies were conducted 
on the diagnosis of pulmonary nodules,
13-14
 classification of benign and malignant 
tumors,
15
 and pulmonary tuberculosis analysis and disease prediction
16-18
 worldwide. 
In this study, multiple CNN models were used to classify CT image datasets and 
calculate the infection probability of COVID-19. The findings might greatly assist in 
the early screening of patients with COVID-19. 
2. Method 
2.1 Dataset introduction 
A total of 618 transverse-section CT samples were collected in this study, including 
219 from 110 patients with COVID-19 from the First Affiliated Hospital of Zhejiang 
University, the No.6 People’s Hospital of Wenzhou, and the No.1 People’s Hospital of 
Wenling , from Jan 19 to Feb 14, 2020. All three hospitals are designated COVID-19 
hospitals in Zhejiang Province. Every COVID-19 patient was confirmed with RT-PCR 
testing kit and we also excluded the cases that had no image manifestations on the 
chest CT images. In addition, there had at least two days gap between CT datasets if 
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taken from the same patient to ensure the diversity of samples. The remaining 399 CT 
samples were collected from the First Affiliated Hospital of Zhejiang University as 
the controlled experiment group. Among them, 224 CT samples were from 224 
patients with Influenza-A viral pneumonia including H1N1, H3N2, H5N1, H7N9 etc., 
and 175 CT samples from healthy people. There were 198 (90.4%) COVID-19 and 
(196) 86.6% Influenza-A cases from early or progressive stages and the rest 9.6% and 
13.4% cases from severe stage respectively (P > 0.05). Moreover, Influenza-A viral 
pneumonia CT cases used as it was most critically to distinguish them from suspected 
patients with COVID-19 currently in China. 
The ethics committee of the First Affiliated Hospital, College of Medicine, 
Zhejiang University approved this study and all research was performed in 
accordance with relevant guidelines/regulations. All participants and/or their legal 
guardians signed the informed consent form before the study.  
A total of 528 CT samples (85.4%) were used for training and validation sets, 
including 189 samples of patients with COVID-19, 194 samples from patients with 
Influenza-A viral pneumonia, and 145 samples from healthy people. The remaining 
90 CT sets (14.6% ) were used as the test set, including 30 COVID-19, 30 
Influenza-A viral pneumonia, and 30 healthy case. Furthermore, the test cases of CT 
set were selected from the people who had not been included in the training stage.  
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(a) (b) (c) 
Figure 1. Typical transverse-section CT images: (a) COVID-19; (b) 
Influenza-A viral pneumonia; (c) no pneumonia manifestations on this chest 
CT image. 
2.2 Process 
Figure 2 shows the whole process of COVID-19 diagnostic report generation in this 
study. First, the CT images were preprocessed to extract effective pulmonary regions. 
Second, a 3D CNN model was used to segment multiple candidate image cubes. The 
center image, together with the two neighbors of each cube, was collected for further 
steps. Third, an image classification model was used to categorize all the image 
patches into three types: COVID-19, Influenza-A-viral-pneumonia, and 
irrelevant-to-infection. Image patches from the same cube voted for the type and 
confidence score of the candidate as a whole. Finally, the overall analysis report for 
one CT sample was calculated using the Noisy-or Bayesian function.
19
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Figure 2. Process flow chart. 
2.3 Dataset preprocessing and candidate region segmentation 
To study was expedited using the same method and models in data preprocessing and 
candidate region segmentation stages as a previous study on pulmonary 
tuberculosis.
17
 The focus of infections from pulmonary tuberculosis had multiple 
structures and types, including miliary, infiltrative, caseous, tuberculoma, and cavitary 
etc. Although, the VNET
20
 based segmentation model VNET-IR-RPN
17
 was trained 
for pulmonary tuberculosis purpose, it was verified to be still good enough to separate 
candidate patches from viral pneumonia.  
Moreover, in the study of pulmonary tuberculosis, the VNET-IR-RPN model 
was used both for both segmentation and classification. Only the segmentation-related 
bounding box regression part was preserved, regardless of the classification results, 
because only the former task was required at this stage in this study.   
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2.4 Image data processing and augmentation 
A large number of non-infection regions irrelevant to this study were also separated 
using the 3D segmentation model, including fibrotic structure of pulmonary, 
calcification spots, or healthy regions identified incorrectly. Therefore, an extra 
category was added as irrelevant-to-infection besides COVID-19 and 
Influenza-A-viral-pneumonia. 
The study included 618 CT samples (219 COVID-19, 224 
Influenza-A-viral-pneumonia, and 175 healthy case). Subsequently, a total of 3957 
candidate cubes were generated from the 3D segmentation model. Only the territory 
close to the middle of this cube contained maximum information about this focus of 
infection. Hence, only the center image together with the two neighbors of each cube 
was collected to represent this region for future classification steps. Next, all image 
patches were manually classified by two professional radiologists into two types: 
irrelevant-to-infection and pneumonia. The the images in the latter category were 
recognized automatically as COVID-19 or Influenza-A-viral-pneumonia based on the 
clinical diagnosis results.  
A total of 11,871 image patches were acquired from the aforementioned steps, 
including 2,634 COVID-19, 2,661 Influenza-A-viral-pneumonia, and 6,576 
irrelevant-to-infection. According to the previous dataset assignment, the training and 
validation sets had 528 CT samples, equivalent to 10,161 (85.6%) images, including 
2,301 COVID-19, 2,244 Influenza-A-viral-pneumonia, and 5,616 
irrelevant-to-infection images. The remaining 1,710 (14.4%) images were reserved for 
  12 / 29 
 
the test dataset.  
The sampling possibility of COVID-19 and Influenza-A-viral-pneumonia cases 
was expanded three times to balance the specimen number of irrelevant-to-infection 
so as to reduce the influence of the uneven distribution of different image types on the 
present dataset. At the same time, generic data expansion mechanisms, such as 
random clipping, left-right, up-down flipping, and mirroring operation, were 
performed on specimens to increase the number of training samples and prevent data 
overfitting. 
2.5 Deep learning model for classification 
2.5.1 Location-attention classification 
The work of Jeffrey Kanne
21
 and Chung M et al,
22
 showed at least three 
distinguishing features of COVID-19: ground-glass appearance, striking peripheral 
distribution along with the pleura, and usually more than one independent focus of 
infections for one case, as showed in Figure 3.  
The models were optimized based on these findings. The image classification 
model was designed to distinguish the appearance and structure of different infections. 
Moreover, relative distance-from-edge as an extra weights, was used for the model to 
learn the relative location information of the patch on the pulmonary image. The focus 
of infections located close to the pleura were be more likely to be recognized as 
COVID-19.  
The relative distance-from-edge of each patch was calculated as followings:  
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1) Measure the minimum distance from the mask to the center of this patch 
(double-headed arrow as showed in Fig 3c) 
2) Obtain the diagonal of the minimum circumscribed rectangle of the pulmonary 
image (Fig 3d) 
3) Then the relative distance-from-edge achieved by the distance obtained from step 
1) divided by the diagonal from step 2).  
  
    
(a) (b) (c) (d) 
Figure 3. (a) COVID-19 image with three ground-glass focus of infections; 
(b) Influenza-A-viral-pneumonia image with four focus of infections; (c) the 
minimum distance from the mask to the center of this patch (double-headed 
arrow) and (d) diagonal of the minimum circumscribed rectangle of this 
pulmonary image. 
2.5.2 Network structure 
Two CNN three-dimensional classification models were evaluated in this study, as 
showed in Figure 4. One was a relative traditional ResNet
23
-based network and 
another model was designed based on the first network structure by concatenating the 
location-attention mechanism in the full-connection layer to improve the overall 
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accuracy rate.  
The classical ResNet-18 network structure was used for image feature 
extraction. Pooling operations were also used for the dimensional reduction of data to 
prevent overfitting and improve the problem of generalization.  
The output of the convolution layer was flattened to a 256-dimensional feature vector 
and then converted into a 16-dimensional feature vector using a full-connection 
network. For the location-attention network, the value of relative distance-from-edge 
was first normalized to the same order of magnitude and then concatenated to this 
full-connection network structure. Next, three full-connection layers were followed to 
output the final classification result together with the confidence score.  
 
60×60×3 30×30×16
...
30×30×32
15×15×16
8×8×4
256
COVID-19
Influenza-A-
viral-pneumonia
30×30×16 30×30×16
Resnet-18 
concatenate operationfull connection
conv2d + maxpooling flatten operation
repeated 
18 times
16+116
8
3
irrelevant-
to-infection
relative distance-
from-edge
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Figure 4. Network structure of the location-attention oriented model. 
2.6 Diagnostic report 
2.6.1 Vote for each candidate region 
Inspired by the theory of Bagging prediction algorithm
24
 in machine learning 
technology, one candidate region was represented by three image patches: the center 
image together with its two neighbors. These three images voted for this whole region 
with the following strategies: 
1) If at least two images were categorized into the same type, then the image with the 
maximum confidence score in this type was selected 
2) Otherwise, the image with the maximum confidence score was picked (no type 
dominated). 
Regions that voted as irrelevant-to-infection type was ignored in the next step. 
2.6.2 Noisy-or Bayesian function to deduce the overall report  
One of the remarkable features of COVID-19 is more than one independent focus of 
infections in one CT case. It is reasonable that the overall probability is much larger 
than 50% if a patient has two COVID-19 regions, both having a 50% probability. 
Accordingly, the total infection confidence score (P) for one infection type was 
calculated using the probability formula of the Noisy-or Bayesian function as follows: 
 
i
iPP )1(1         (1) 
where iP  
represents the confidence of the ith region. 
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The confidence scores of two types 19COVIDP   and Influenza A viral pneumoniaP     were 
deduced accordingly, then this CT sample was categorized to the corresponding group 
according to the dominated P value.  
Moreover, the following strategies were used output the confidence possibility of an 
entire CT sample for a reasonable reference to clinical doctors:  
1. If both P  values were equal to 0, then this CT sample belonged to the 
no-infection-found case 
2. If one of the P  values was equal to 0, then the other P  value was exported 
directly as the confidence possibility of this CT sample 
3. Otherwise, the softmax function was used to generate two confidence scores.  
i
j
P
i P
j
e
S
e


                            (2) 
where 9, ),( 1COVID Influenza A viral pneumoi j nia    . Both iS  was exported 
as the confidence score for each type of infection. The softmax operation normalized 
the sum of iS  to 100% and did not alter the judgment result of infection types. 
3. Results 
3.1 Evaluation platform 
An Intel i7-8700k CPU together with NVIDIA GPU GeForce GTX 1080ti was used 
as the testing server. The processing time largely depended on the number of image 
layers in one CT set. On average, it was less than 30s for a CT set with 70 layers from 
data-preprocessing to the output of the report. 
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3.2 Training process 
As one of the most classical loss function used in classification models, cross-entropy 
was used in this study. When the epoch number of training iterations increased to 
more than 1000, the loss value did not decrease or increase obviously, suggesting that 
the models converged well to a relative optimal state without distinct overfitting. The 
training curves of the loss value and the accuracy for two classification models were 
showed in Figure 5. The network with the location-attention mechanism achieved 
better performance on the training dataset compared with the original ResNet.  
 
Figure 5. Training curve of loss and accuracy for the two classification 
models. 
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3.3 Performance on test dataset 
3.3.1 Performance measurement   
The accuracy of a method determines how correct the values are predicted. Precision 
determines the reproducibility of the measurement or how many of the predictions are 
correct. Recall shows how many of the correct results are discovered. F1-score uses a 
combination of precision and recall to calculate a balanced average result. The 
following equations show how to calculate these values, where TP, TN, FP and FN are 
true positive, true negative, false positive, and false negative respectively. 
TP TN
accuracy
TP FP TN FN


  
                            (3) 
TP
precision
TP FP


                                     (4) 
TP
recall
TP FN


                                       (5) 
2
1
precision recall
f score
precision recall
 
 

                           (6) 
3.3.2 Segmentation 
A total of 30 CT samples were selected randomly from each group (COVID-19, 
Influenza-A-viral-pneumonia and healthy) for the test set, following the rule that this 
person (owner of this CT) had not been included in the previous training stage. 
Moreover, the segmentation model VNET-IR-RPN was configured to reduce the 
proposal's threshold to maximum separate candidate regions even through many 
normal regions could be included in. One CT case from COVID-19 group that had no 
region segmented as COVID-19 or Influenza-A-viral-pneumonia and hence wrongly 
categorized into the no-infection-found group, as showed in Figure 6. These focus of 
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infections could be barely notified by human eyed and seemed too tenuous to be 
captured by the segmentation model for this study. 
 
   
(a) (b) (c) 
Figure 6. All CT images from a single CT case. The focus of infections are 
pointed out by arrows. 
3.3.3 Classification for a single image patch 
A total of 1,710 image patches were acquired from 90 CT samples, including 357 
COVID-19, 390 Influenza-A-viral-pneumonia, and 963 irrelevant-to-infection 
(ground truth). To determine which was the optimal approach, the design of each 
methodology was assessed using a confusion matrix. Two network structures were 
evaluated: with and without the location-attention mechanism, as showed in Table 1 
and Table 2. 
 
 
Predicted result 
COVID-19 
(M1/M2) 
IAVP  
(M1/M2) 
ITI  
(M1/M2) 
Actual 
result 
COVID-19 (M1/M2) 260/273 47/32 50/52 
IAVP (M1/M2) 55/46 276/280 59/64 
ITI (M1/M2) 75/77 81/82 807/804 
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Table 1. The confusion matrix of COVID-19, 
Influenza-A-viral-pneumonia (IAVP) and irrelevant-to-infection (ITI). M1 
and M2 referred to ResNet model and ResNet with location-attention 
mechanism model.
 
 
 Recall (M1,M2) Precision (M1,M2) f1-score (M1,M2) 
COVID-19 (M1,M2) 0.728/0.765 0.667/0.689 0.696/0.725 
IAVP (M1,M2) 0.708/0.718 0.683/0.711 0.695/0.714 
ITI (M1,M2) 0.838/0.835 0.881/0.874 0.859/0.854 
 
Table 2. The recall, precision and f1-score of two classification models for 
COVID-19, Influenza-A-viral-pneumonia (IAVP) and 
irrelevant-to-infection (ITI). M1 and M2 referred to ResNet model and 
ResNet with location-attention mechanism model.  
 
The average f1_scores for two models were 0.750 and 0.764, which indicated that the 
second model with location-attention mechanism achieved better performance 
averagely. Therefore, this model was used for the rest of this study.  
3.3.4 Vote for a region 
Each image patch voted to represent this entire candidate region. A total of 570 
candidate cubes were distinguished, including 119 COVID-19, 130 
Influenza-A-viral-pneumonia and 321 irrelevant-to-infection regions (ground truth). 
The confusion matrix of voting result and corresponding recall, precision and f1-score 
were showed in Table 3 and Table 4. The average f1-score for three categories was 
0.856 and had an improvement of 12.1% compared with previous step. 
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Predicted result 
COVID-19  IAVP  ITI  
Actual 
result 
COVID-19 97 15 7 
IAVP 18 98 14 
ITI 5 2 314 
 
Table 3. The confusion matrix of COVID-19, 
Influenza-A-viral-pneumonia (IAVP) and irrelevant-to-infection (ITI). 
 
 Recall Precision f1-score  
Actual 
result 
COVID-19 0.815 0.808 0.811 
IAVP 0.754 0.852 0.800 
ITI 0.978 0.937 0.957 
 
Table 4. The recall, precision and f1-score of after voting process for each 
regions: COVID-19, Influenza-A-viral-pneumonia (IAVP) and 
irrelevant-to-infection (ITI). 
3.3.5 Result of the classification for the CT samples as a whole 
Noisy-or Bayesian function was used to identify the dominated infection types. Three 
types result exported in the final report: COVID-19, Influenza-A-viral-pneumonia and 
no-infection-found. The experimental results are summarize in Table 5 and Table 6. 
As the irrelevant-to-infection items (previous step) would be ignored and not be 
counted by the Bayesian function, we only compare the average f1-score for the first 
two items. They were 0.806 and 0.843 respectively, which showed a promotion of 
4.7%. Moreover, the overall classification accuracy for all three groups are 86.7%.  
 
 
Predicted result 
COVID-19  IAVP  NIF  
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Actual 
result 
COVID-19 26 3 1 
IAVP 4 25 1 
NIF 2 1 27 
 
Table 5. The confusion matrix of COVID-19, 
Influenza-A-viral-pneumonia (IAVP) and no-infection-found (NIF). 
 
 Recall Precision f1-score  
Actual 
result 
COVID-19 0.867 0.813 0.839 
IAVP 0.833 0.862 0.847 
NIF 0.900 0.931 0.915 
 
Table 6. The recall, precision and f1-score from the output of the Bayesian 
function for COVID-19, Influenza-A-viral-pneumonia (IAVP) and 
no-infection-found (NIF). 
4. Discussion 
COVID-19, which was first detected in Wuhan China, has caused serious public 
health safety problems and hence become a global concern.
25-27
 The severe situation 
puts forward new requirements for the prevention and control strategy. A large 
number of patients with viral pneumonia had been detected in Wuhan city. The 
RT-PCR test of 2019-nCoV RNA can make a definite diagnosis of COVID-19 from 
Influenza-A viral pneumonia patients. However, the nucleic acid testing has some 
defects, such as time lag, relatively low detection rate, and short of supply. In the 
early stage of COVID-19, some patients may already have positive pulmonary 
imaging findings but they have no sputum and negative test results in nasopharyngeal 
swabs of RT-PCR. These patients are not diagnosed as suspected or confirmed cases. 
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Thus, they are not be isolated or treated for the first time, making them potential 
sources of infection.  
The CT imaging of COVID-19 present several distinct manifestations according 
to previous studies.
21,22
 The manifestations include focal ground glass shadows 
mainly distributed in bilateral lungs, multiple consolidation shadows accompanied by 
the "halo sign" of surrounding ground glass shadow in both lungs, mesh shadows and 
bronchiectasis and inflating signs inside the lesions, and multiple consolidation of 
different sizes and grid-shaped high-density shadows. However, it is not objective and 
accurate to distinguish COVID-19 from other diseases only with human eyes. In 
comparison, deep learning system-based screen models revealed more specific and 
reliable results by digitizing and standardizing the image information. Hence, they can 
assist physicians to make a quick clinical decision more accurately, which would 
benefit on management of suspected patients.  
In this study, the deep learning technology was used to design a classification 
network for distinguishing the COVID-19 from Influenza-A viral pneumonia. In 
terms of the network structure, the classical ResNet was used for feature extraction. It 
was compared with the network model with and without the added location-attention 
mechanism. The experiment showed that the aforementioned mechanism could better 
distinguish COVID-19 cases from others.  
The manifestation of COVID-19 may have some overlap with the 
manifestations of other pneumonias such as Influenza-A viral pneumonia, organic 
pneumonia and eosinophilic pneumonia. The clinical diagnosis of COVID-19 needs 
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to combine the patients’ contact history, travel history, first symptoms and laboratory 
examination. In this study, the number of model samples was limited. Hence, the 
training and test the number of samples should be expand to improve the accuracy in 
the future. More multi-center clinical studies should be conducted to cope with the 
complex clinical situation. 
Moreover, efforts should be made to improve the segmentation and 
classification model. A better exclusive models should be designed for training, the 
segmentation and classification accuracy of the model should be improved, and the 
generalization performance of this algorithm should be verified with a larger data set.  
5. Conclusion 
In this multi-center case study, we had presented a novel method that could screen 
COVID-19 fully automatically by deep learning technologies. Models with 
location-attention mechanism could more accurately classify COVID-19 at chest 
radiography with the overall accuracy rate of 86.7 % and could be a promising 
supplementary diagnostic method for frontline clinical doctors.   
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